, ,
Presentations this author is a contributor to:
                  
          
          Evaluation of Closed Loop Performance in Adults with Type 1 Diabetes Undertaking Anaerobic Versus Aerobic Exercise: A Randomised Crossover Study (#82)
  
  8:45 AM
      
    Dilshani Jayawardene    
  
          
            
            ADS President's Clinical Young Investigator Award          
        
                        
          
          Trajectories of eGFR decline over a four year period: the eGFR Follow-up Study (#32)
  
  11:30 AM
      
    Federica Barzi    
  
          
            
            ADS Clinical Orals - Renal & Foot Complications          
        
                        
          
          Exercise capacity (VO2max) is reduced in Type 2 diabetes mellitus (T2DM) but not Type 1 (T1DM), and is not due to diastolic dysfunction (#141)
  
  5:15 PM
      
    Timothy J Roberts    
  
          
            
            ADS Clinical Orals - Pregnancy, diet & exercise          
        
                        
          
          Pulmonary microvascular disease in diabetes mellitus (DM) subjects detected by exercise echocardiography is not associated with reduced exercise capacity (#85)
  
  9:30 AM
      
    Timothy J Roberts    
  
          
            
            ADS President's Clinical Young Investigator Award          
        
                        
          
          Functional Magnetic Resonance Imaging (MRI) changes in Type 1 Diabetes with and without Renal Hyperfiltration (#221)
  
  2:00 PM
      
    Jas-mine Seah    
  
          
            
            ADS Clinical Poster Award Session          
        
                        
          
          The contribution of glycaemic status to the progression of kidney disease among Indigenous Australians with and without albuminuria– the eGFR follow-up study (#30)
  
  11:00 AM
      
    Elizabeth LM Barr    
  
          
            
            ADS Clinical Orals - Renal & Foot Complications          
        
                        
          
          Tumour Necrosis Factor-alpha Receptor 1 and 2 are Reduced in patients with Type 1 Diabetes and Hyperfiltration (#34)
  
  12:00 PM
      
    Jas-mine Seah    
  
          
            
            ADS Clinical Orals - Renal & Foot Complications          
        
                        
          
          Audit of Diabetes Management Guidelines for the Cancer Centre during the Pilot Phase (#59)
  
  4:15 PM
      
    Peter G Colman    
  
          
            
            ADS Clinical Orals - Type 2 Therapies          
        
                        
          
          Regulation of alpha cell function and fatty acid levels by hyperinsulinaemia after islet cell transplantation in Type 1 diabetes (#166)
  
  10:45 AM
      
    Glenn M Ward    
  
          
            
            ADS Clinical Orals - Type 1 Diabetes          
        
            
 ADS-ADEA 2016*
                ADS-ADEA 2016*